["{\n\"step_by_step_thinking\": \"The relevant documents suggest that antiretroviral therapy has limitations due to the progressive impairment of the immune system during HIV infection. Additionally, the discovery of dideoxynucleosides like AZT has led to some success in prolonging life and partially reversing HIV dementia. However, the use of these drugs is associated with toxicities, particularly bone marrow suppression, and the development of AZT-resistant strains of HIV. Furthermore, the issue of drug resistance is a significant concern globally, including developing countries like those in sub-Saharan Africa. Therefore, it is unlikely that sub-Saharan Africa can cope with the new \"test and treat\" policy of the World Health Organization without proper consideration of these limitations and challenges.\",\n\"answer_choice\": B"]